CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...
Zacks Investment Research on MSN
Here's how AbbVie's neuroscience portfolio is aiding top-line growth
AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and ...
Dean's sophomore album "The Art Of Loving" leads the ARIA Albums Chart for a fifth non-consecutive week, while "Man I Need" ...
US stocks are detached from GDP growth; buybacks and incentives boost gains but risk negative real S&P 500 returns over 13 ...
Across some of the year's most acclaimed films, women made private struggles with mental health a little more universal.
1 Mental Health Centre “Prof. N. Shipkovenski”, Sofia, Bulgaria. 2 Department of Neurology and Psychiatry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria. The classification of depressive ...
Johnson & Johnson Q4 Earnings Loom As FDA Approves Depression Drug: Will Long-Term Weakness Reverse?
Johnson & Johnson’s Spravato gains FDA approval for standalone depression treatment ahead of Q4 earnings. JNJ stock shows short-term bullish signals, but long-term trends remain bearish ahead of ...
A meteoric rise to fame can be a tough adjustment for anyone, and singer-songwriter Chappell Roan is no different. In an interview on Friday with the Guardian, Roan -- aka Kayleigh Rose Amstutz -- ...
Singer Chappell Roan has revealed she’s been diagnosed with severe depression and is in therapy, after receiving a backlash from some fans about her attitude towards her growing profile. Roan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback